Company Protia Inc.

Equities

A303360

KR7303360002

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
3,050 ^KRW	+0.49%		-0.65%	-6.73%

2022	ProteomeTech Inc. has filed an IPO.	CI
2019	ProteomeTech Inc. announced that it has received KRW 4.999995 billion in funding from POSCO Venture Capital Co., Ltd. and another investor	CI

Protia Inc, formerly ProteomeTech Inc is a company mainly engaged in the production and sale of diagnostic kits. The Company mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.

KRW in Million	2022	Weight	2023	Weight	Delta
Diagnostic Kits and Diagnostic Equipment Product 95.2 %	-	-	7,835	95.2 %	-
Other 2.4 %	184	2.4 %	198	2.4 %	+7.98%
Analysis Service 2.4 %	297	3.9 %	194	2.4 %	-34.50%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 55.6 %	4,416	57.8 %	4,574	55.6 %	+3.58%
Asia 27.6 %	1,626	21.3 %	2,274	27.6 %	+39.89%
Europe 14.0 %	1,326	17.3 %	1,148	14.0 %	-13.43%
North and Central America 1.3 %	131	1.7 %	107	1.3 %	-18.26%
Africa 1.0 %	103	1.3 %	80	1.0 %	-22.25%
South America 0.4 %	20	0.3 %	34	0.4 %	+70.00%
Others 0.1 %	23	0.3 %	11	0.1 %	-52.10%

Managers	Title	Age	Since
Kook-Jin Lim CEO	Chief Executive Officer	63	31/05/10
Myeong-Suk Jeong BRD	Director/Board Member	64	31/12/09
Bum-Jun Kim BRD	Director/Board Member	56	-
Seong-Jin Park AUD	Comptroller/Controller/Auditor	63	-

Members of the board	Title	Age	Since
Kook-Jin Lim CEO	Chief Executive Officer	63	31/05/10
Bum-Jun Kim BRD	Director/Board Member	56	-
Yu-Sam Kim BRD	Director/Board Member	81	-
Myeong-Suk Jeong BRD	Director/Board Member	64	31/12/09
Ji-Hun Jeong BRD	Director/Board Member	45	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,877,215	6,709,988 ( 52.11 %)	0	52.11 %

Name	Equities	%	Valuation
Kook-Jin Lim 24.38 %	3,139,929	24.38 %	6 M ₩
Myung-sook Chung 6.521 %	839,760	6.521 %	2 M ₩
Hanwha Investment & Securities Co. Ltd. /Venture Capital/ 3.251 %	418,605	3.251 %	849 567 ₩
Seong-Bae Namgung 2.517 %	324,168	2.517 %	657 905 ₩
Jong-bok Yoon 1.676 %	215,880	1.676 %	438 133 ₩
Song-eun Lim 0.7570 %	97,476	0.7570 %	197 829 ₩
Sung-hee Lim 0.7298 %	93,982	0.7298 %	190 738 ₩
Soo-yeon Lim 0.6989 %	90,000	0.6989 %	182 657 ₩
Dong-seop Choi 0.6031 %	77,661	0.6031 %	157 615 ₩
Dong-wook Hong 0.4659 %	60,000	0.4659 %	121 771 ₩

Protia, Inc.

Unit702, Hangang Zy Tower A 401, Yangcheon-ro

07528, Seoul

http://www.protia.co.kr

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
PROTIA INC.	-6.73%	28.63M
BIOMÉRIEUX	-6.76%	12.28B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.68%	8.05B
DIASORIN S.P.A.	+8.91%	5.84B
LANTHEUS HOLDINGS, INC.	+28.87%	5.66B
AUTOBIO DIAGNOSTICS CO., LTD.	-15.84%	3.99B
ANDON HEALTH CO., LTD.	+10.70%	2.7B
10X GENOMICS, INC.	-60.92%	2.7B
VITROLIFE AB	-6.99%	2.39B
MYRIAD GENETICS, INC.	+15.67%	2.02B

Diagnostic & Testing Substances